US Patent 9216217 Oligomer-specific amyloid beta epitope and antibodies
Patent 9216217 was granted and assigned to The University Of British Columbia on December, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9216217 Oligomer-specific amyloid beta epitope and antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.